Literature DB >> 17949513

Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS.

Elena Michaelovsky1, Doron Gothelf, Michael Korostishevsky, Amos Frisch, Merav Burg, Miri Carmel, Tamar Steinberg, Dov Inbar, Alan Apter, Abraham Weizman.   

Abstract

The 22q11.2 deletion syndrome (22q11.2DS) is the most common hemizygous deletion syndrome in humans. In addition to a wide range of physical abnormalities 22q11.2DS subjects show high prevalence of several psychiatric disorders. In our previous study we showed that the low-activity allele (158Met) of the COMT gene is a risk factor for attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD) in 22q11.2DS individuals. In the present study we have genotyped fifty-five 22q11.2DS individuals and 95 of their parents for eight SNPs in and around the COMT gene. A haplotype composed of three SNPs [rs2097603; rs4680 (158Val/Met); rs165599] representing the major linkage disequilibrium blocks in COMT and previously implicated in functional variation, was found to be associated with ADHD and OCD in 22q11.2DS individuals. A common risk haplotype (G-A-A) was significantly associated with both ADHD (OR 3.13, chi2=4.38, p=0.036) and OCD (OR 4.00, chi2=6.41, p=0.011) in 22q11.2DS individuals. Interestingly, the same haplotype was recently found to be associated with efficient prefrontal performance in the general population. The risk haplotype was not found to be associated with IQ scores in our 22q11.2DS sample. Parental origin of the deletion did not affect the susceptibility to ADHD and OCD in the 22q11.2DS subjects. This study demonstrated the association of a particular COMT haplotype with susceptibility to both ADHD and OCD in 22q11.2DS and supports the hypothesis that COMT gene variations contribute to genetic predisposition to psychiatric disorders in the general population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949513     DOI: 10.1017/S1461145707008085

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  27 in total

1.  DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.

Authors:  Yannis Paloyelis; Philip Asherson; Mitul A Mehta; Stephen V Faraone; Jonna Kuntsi
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

2.  Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Amanda J Law; Amos Frisch; Jingshan Chen; Omer Zarchi; Elena Michaelovsky; Renee Ren-Patterson; Barbara K Lipska; Miri Carmel; Bhaskar Kolachana; Abraham Weizman; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

Review 3.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 4.  Insights into brain development from neurogenetic syndromes: evidence from fragile X syndrome, Williams syndrome, Turner syndrome and velocardiofacial syndrome.

Authors:  E Walter; P K Mazaika; A L Reiss
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

5.  COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome.

Authors:  Vandana Shashi; Timothy D Howard; Matcheri S Keshavan; Jessica Kaczorowski; Margaret N Berry; Kelly Schoch; Edward J Spence; Thomas R Kwapil
Journal:  Psychiatry Res       Date:  2010-05-20       Impact factor: 3.222

6.  Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Christian R Marshall; Anath C Lionel; Eva W C Chow; Stephen W Scherer
Journal:  Hum Mol Genet       Date:  2008-09-20       Impact factor: 6.150

Review 7.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

8.  Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant.

Authors:  Haukur Pálmason; Dirk Moser; Jessica Sigmund; Christian Vogler; Susann Hänig; Anna Schneider; Christiane Seitz; Alexander Marcus; Jobst Meyer; Christine M Freitag
Journal:  J Neural Transm (Vienna)       Date:  2009-11-28       Impact factor: 3.575

9.  Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: enrichment for marker SNPs.

Authors:  Andrea G Nackley; Svetlana A Shabalina; Jason E Lambert; Mathew S Conrad; Dustin G Gibson; Alexey N Spiridonov; Sarah K Satterfield; Luda Diatchenko
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

10.  Tourette syndrome and klippel-feil anomaly in a child with chromosome 22q11 duplication.

Authors:  Raymond A Clarke; Zhi Ming Fang; Ashish D Diwan; Donald L Gilbert
Journal:  Case Rep Med       Date:  2009-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.